LicianPro

Beta Bionics, Inc. ·

BBNX 8-K 2026-09-17

Beta Bionics, Inc. (BBNX) 8-K dated 2026-09-17 — accession 0001193125-26-393322.

Beta Bionics, Inc. (BBNX) is a medical devices company listed on NASDAQ.

Beta Bionics, Inc. filed a 8-K on 2026-09-17. Accession 0001193125-26-393322.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.

Not investment advice. The BBNX SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr